AspenBio Pharma, Inc. Stock Nasdaq
Equities
US0453462022
Blockchain & Cryptocurrency
End-of-day quote
Other stock markets
|
||
- USD | - |
Apr. 25 | Top Cryptocurrencies Mixed; Bitcoin Hovers Above $64,000 | MT |
Apr. 24 | Top Cryptocurrencies Fall; Bitcoin Falls Near $64,000 | MT |
Financials (USD)
Sales 2024 * | 493M | Sales 2025 * | 905M | Capitalization | 3.07B |
---|---|---|---|---|---|
Net income 2024 * | -141M | Net income 2025 * | 254M | EV / Sales 2024 * | 3.49 x |
Net cash position 2024 * | 1.35B | Net cash position 2025 * | 1.9B | EV / Sales 2025 * | 1.3 x |
P/E ratio 2024 * |
-22.8
x | P/E ratio 2025 * |
19
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.76% |
Managers | Title | Age | Since |
---|---|---|---|
Jason Les
CEO | Chief Executive Officer | 38 | 17-11-02 |
Colin Yee
DFI | Director of Finance/CFO | 48 | 22-03-31 |
David Schatz
COO | Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Hubert Marleau
BRD | Director/Board Member | 80 | 20-11-16 |
Lance D'Ambrosio
BRD | Director/Board Member | 66 | 21-05-23 |
Benjamin Yi
CHM | Chairman | 42 | 18-10-21 |
1st Jan change | Capi. | |
---|---|---|
-18.52% | 5.09B | |
+69.90% | 4.4B | |
-1.34% | 3.61B | |
+9.08% | 1.29B | |
-35.40% | 767M | |
+0.83% | 753M | |
-29.35% | 713M | |
-72.47% | 492M | |
-54.60% | 368M |